🚀 VC round data is live in beta, check it out!
Beijing Balance Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Beijing Balance Medical and similar public comparables like Draegerwerk, Jeol, BoneSupport, VCANBIO and more.
Beijing Balance Medical Overview
About Beijing Balance Medical
Beijing Balance Medical Technology Co Ltd is engaged in the research and development and production of animal-derived implantable medical devices. The company's products are used in heart valve replacement and repair, congenital heart disease implant intervention and surgical soft tissue repair.
Founded
2005
HQ
Employees
N/A
Website
Financials (FY)
EV
$2B
Beijing Balance Medical Financials
Beijing Balance Medical reported last fiscal year revenue of $74M and EBITDA of $26M.
In the same fiscal year, Beijing Balance Medical generated $65M in gross profit, $26M in EBITDA, and $21M in net income.
Beijing Balance Medical P&L
In the most recent fiscal year, Beijing Balance Medical reported revenue of $74M and EBITDA of $26M.
Beijing Balance Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $74M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $65M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 88% | XXX | XXX | XXX |
| EBITDA | — | XXX | $26M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 35% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 28% | XXX | XXX | XXX |
| Net Profit | — | XXX | $21M | XXX | XXX | XXX |
| Net Margin | — | XXX | 29% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Beijing Balance Medical Stock Performance
Beijing Balance Medical has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Beijing Balance Medical's stock price is $13.74.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | 0.0% | XXX | XXX | XXX | $0.16 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBeijing Balance Medical Valuation Multiples
Beijing Balance Medical trades at 25.3x EV/Revenue multiple, and 72.9x EV/EBITDA.
Beijing Balance Medical Financial Valuation Multiples
As of April 20, 2026, Beijing Balance Medical has market cap of $2B and EV of $2B.
Equity research analysts estimate Beijing Balance Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Beijing Balance Medical has a P/E ratio of 88.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 25.3x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 72.9x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 92.1x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 28.7x | XXX | XXX | XXX |
| P/E | — | XXX | 88.2x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (470.8x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Beijing Balance Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Beijing Balance Medical Margins & Growth Rates
Beijing Balance Medical's revenue in the last fiscal year grew by 35%.
Beijing Balance Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 35% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 35% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 30% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 15% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 30% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 61% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Beijing Balance Medical Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Beijing Balance Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Draegerwerk | XXX | XXX | XXX | XXX | XXX | XXX |
| Jeol | XXX | XXX | XXX | XXX | XXX | XXX |
| BoneSupport | XXX | XXX | XXX | XXX | XXX | XXX |
| VCANBIO | XXX | XXX | XXX | XXX | XXX | XXX |
| Embla Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Beijing Balance Medical M&A Activity
Beijing Balance Medical acquired XXX companies to date.
Last acquisition by Beijing Balance Medical was on XXXXXXXX, XXXXX. Beijing Balance Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Beijing Balance Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBeijing Balance Medical Investment Activity
Beijing Balance Medical invested in XXX companies to date.
Beijing Balance Medical made its latest investment on XXXXXXXX, XXXXX. Beijing Balance Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Beijing Balance Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Beijing Balance Medical
| When was Beijing Balance Medical founded? | Beijing Balance Medical was founded in 2005. |
| Where is Beijing Balance Medical headquartered? | Beijing Balance Medical is headquartered in China. |
| Is Beijing Balance Medical publicly listed? | Yes, Beijing Balance Medical is a public company listed on Shanghai Stock Exchange. |
| What is the stock symbol of Beijing Balance Medical? | Beijing Balance Medical trades under 688198 ticker. |
| When did Beijing Balance Medical go public? | Beijing Balance Medical went public in 2019. |
| Who are competitors of Beijing Balance Medical? | Beijing Balance Medical main competitors are Draegerwerk, Jeol, BoneSupport, VCANBIO. |
| What is the current market cap of Beijing Balance Medical? | Beijing Balance Medical's current market cap is $2B. |
| What is the current revenue of Beijing Balance Medical? | Beijing Balance Medical's last fiscal year revenue is $74M. |
| What is the current EV/Revenue multiple of Beijing Balance Medical? | Current revenue multiple of Beijing Balance Medical is 25.3x. |
| Is Beijing Balance Medical profitable? | No, Beijing Balance Medical is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.